Objective: The objective of this study was to assess midterm functional status, wound healing, and in-hospital resource use among a prospective cohort of patients treated in a tertiary hospital, multidisciplinary Center for Limb Preservation.
Management of patients with chronic limb-threatening ischemia is highly complex and resource intensive. These patients require rapid assessment and control of medical comorbidities; they may need multiple vascular and podiatric interventions, involvement of prosthetics or orthotics, and long-term surveillance to avoid recurrent wounds and readmissions. 1 Foot ulcers and amputations cost the U.S. health care system an estimated $29 billion in 2007. 2 Lower extremity amputations are associated with functional disability, including impaired ambulation and self-care, social, emotional, and occupational issues. Health care expenditure does not end with an amputation. In the Veterans Health Administration system, the economic burden associated with lower extremity amputations in diabetic patients exceeded $2 billion in 2010. 3 Previous studies have looked at factors that affect resource use associated with revascularization 1, 4 ; however, there are limited data on overall costs and functional outcomes of these patients and their relationship to the severity of limb threat. Staging of the threatened limb allows meaningful comparison of outcomes for treatment strategies and establishment of benchmarks. [5] [6] [7] We recently reported on the short-term outcomes of patients who were admitted to our Center for Limb Preservation and stratified by the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) lower extremity threatened limb classification scheme. 7 This cohort of patients was hospitalized for treatment of limb-threatening conditions representing the full spectrum of WIfI stages of wound, ischemia, and foot infection. The current study describes longer term results in this population with additional end points of interest, including in-hospital resource use, recurrent events, functional status, wound healing, and limb outcomes. We identify the relationship between WIfI stage at presentation and downstream events and other predictive risk factors.
METHODS
Patient selection and data collection. A single-center retrospective analysis was conducted using prospectively collected data on all consecutive admissions to a multidisciplinary limb preservation service from July 2013 through October 2014, with follow-up data collection through January 31, 2016. Patients were excluded from the study if they presented with nonatherosclerotic disease (eg, vasospastic diseases, vasculitis), acute limb ischemia, or trauma. Baseline demographic and clinical data were collected on admission. Follow-up data on limb-related outcomes, limb-related readmissions, and functional status were collected by review of electronic medical records. For patients with no clear documentation of the relevant data points, an attempt was made to contact the patients by phone or e-mail. Hospital costs (direct) were obtained from a hospital billing database for inpatient admissions only. The study was approved by the Committee on Human Research of the University of California, San Francisco. Individual patient consent was not obtained because of the observational nature of the study.
Limb staging and initial management. The WIfI staging system was used to classify all limbs on admission as described. 5 The vascular surgery and podiatric team were involved in the assessment and scoring of the limb for wound extent and foot infection (0-3). Ischemia was scored (0-3) using noninvasive hemodynamic measures (ankle pressure and toe pressure) per recommendations. 5 Patients were included in the study if hemody- End points. End points included major amputation (defined as transtibial or higher), mortality, index wound healing, functional status at the end of the study period, hospital readmission, and direct costs for inpatient care. Ambulatory functional status was defined as the ability to walk independently or with aids (eg, cane or walker), and nonambulatory functional status was defined as the inability to ambulate independently (eg, use of a wheelchair or bedridden). Functional status was assessed by physician interview and was not always directly observed. All readmissions within 30 days of initial hospitalization and all limb-related readmissions beyond 30 days were included for the analysis. Complete wound healing was defined as healing of the index wound or minor amputations (ie, amputations below the malleolus). Recurrent wounds included new wounds at the same or different locations in the index limb. Direct inpatient costs for limb-related care were collected for the index admission, at time points of 30 days and 1 year from the index admission, and for the total available follow-up period. Recommendation: This study suggests that limb salvage can be achieved with a multidisciplinary team, but these patients require intense inpatient care and are prone to readmissions and recurrence of symptoms and wounds.
analysis was used for time-dependent outcomes and multiple logistic regression was used for all other outcomes. Only variables with a P value of <.2 on univariable analysis were included in the regression analysis. For all statistical analysis, P < .05 was considered statistically significant. For limb-related end points, the analysis was aimed at the number of unique limbs (n ¼ 157). Only limbs with an open wound on presentation (n ¼ 118) were included for wound healing outcomes. Limbs that underwent a major amputation by the end of the study period were excluded from foot wound healing analysis, and 16% of wound healing data was missing. For readmissions and functional status, the total numbers of patients at risk were included for analysis (n ¼ 128). Longitudinal cost analysis focused on subsequent treatment of the index limb and excluded hospitalizations for treatment of a contralateral limb during the follow-up period and patients who had both limbs treated during the index hospitalization. Two models were created for cost analysis; cost per limb saved included only patients with intact limbs at the end of the study period (n ¼ 97), and cost per limb included all limbs (n ¼ 110, inclusive of subjects who underwent a major amputation).
RESULTS
Demographics and midterm outcomes. The cohort included 128 patients with 157 threatened limbs admitted during the study inclusion period. Details of the demographics (Table I) , comorbid conditions, and medical therapies in this cohort have been previously described. 7 Six patients who were deemed unsalvageable on admission and underwent primary major amputation were excluded from both studies. For the current study, we excluded eight limbs that were unstageable (stage 0) from the analysis. There were three patients in the previous study cohort whose data were entered incorrectly, and these limbs and patients were also excluded (n ¼ 3). Median follow-up time (interquartile range) was 395 (80-635) days. During the index admission, 71% of limbs underwent revascularization; the use of revascularization significantly increased by stage, and 56% of the procedures were open surgery and 44% were endovascular procedures. Midterm end points included 12% mortality, 14% major amputations, and 55% complete index wound healing. WIfI stage was significantly associated with major amputation (P < .05; Fig 1) but not with amputation-free survival or time to wound healing (P > .05; Figs 2 and 3, A). Median time to wound healing was 116 days (interquartile range, 52-189 days) for the overall cohort and was not significantly different among the WIfI stages, although it trended longer for stage 3 and stage 4 limbs (Table II) . The WIfI ischemia grade at presentation was significantly associated with time to wound healing (P ¼ .03; Fig 3, B) . On Cox regression analysis, the only factor that was independently associated with time to wound healing was severe (grade 3) limb ischemia at presentation (hazard ratio, 2.6; 95% confidence interval [CI], 1.2-5.8, compared with grade 0 ischemia).
During follow-up, 25% (n ¼ 27/110) of limbs required a secondary vascular intervention, and 45% developed recurrent symptoms or wounds. There was no difference in the rate of recurrent wounds or symptoms in patients who underwent initial open revascularization (52%), no intervention (41%), or endovascular intervention (41%; P ¼ .2). Of the limbs that required a secondary vascular intervention, 46% underwent an open procedure and 54% involved an endovascular intervention. There was no difference in the rate of vascular reintervention or wound recurrence by initial WIfI stage (P > .05). For stage 4 limbs, both amputation-free survival (77% vs 20%) and freedom from major amputation (87% vs 25%; Fig 4) were significantly greater when open bypass surgery was employed as the initial revascularization strategy in comparison to endovascular intervention (P < .05, Kaplan-Meier analysis), but there was no difference in time to index wound healing (P ¼ .6).
Functional status. At time of entry into the study, 10% (n ¼ 13/128) of patients were nonambulatory; and in 8% (n ¼ 10/128), functional status data at the time of index admission were missing. At the end of the study period, after elimination of the patients who died or had missing data, functional status data were available for 89 patients. Of these 89 patients, 23 (26%) were alive and nonambulatory (wheelchair bound or bedridden) at the end of the study period. Of the 23 nonambulatory patients, 5 were previously nonambulatory, 5 patients had a major amputation, and 15 patients had an active lower extremity wound/symptom (either index lesion or new/recurrent wound or symptoms). At the end of the study period, 12 patients had a major amputation and were alive; 6 of these patients were ambulatory. Two different models were used to assess functional status; one exclusively focused on factors present at baseline, and a second model included later clinical events, such as major amputation or presence of an active wound/limb symptoms. In the baseline multivariable model, end-stage renal disease (P ¼ .03; relative risk, 4.3; 95% CI, 1.1-16.5) and initial functional status (P ¼ .02; relative risk, 0.1; 95% CI, 0.01-0.7) were associated with ability to ambulate independently on the last available follow-up (Table III , univariate analysis). In the second model, no factor retained significance at an a of .05.
Hospital readmissions and length of stay. Readmission rate for the overall cohort was about 20% (n ¼ 24/128) within 30 days of index hospital stay; however, 50% (n ¼ 64/128) of patients were readmitted at least once during the entire follow-up period. Of the 24 patients who were readmitted within 30 days, 3 were planned readmissions, 10 patients had a wound infection or complication, 3 patients had recurrent or worsening ischemia of the index limb, 1 patient had contralateral ischemia, and 5 patients had a systemic complication. Mean total number of admissions per patient (6standard deviation) was 1.9 6 1.2, with mean (6standard deviation) cumulative length of stay (cLOS) of 17.1 (617.9) days. There was no difference in the rate of readmission by initial WIfI stage (P > .05); however, cLOS was significantly greater for stage 4 patients (P ¼ .002; Table II (Table IV) . Successful salvage of stage 4 limbs was more expensive across all time periods (P < .05; Fig 5) , whereas there was no difference in the inpatient costs per limb saved among the lower WIfI stages. Costs were significantly higher for stage 4 limbs at all the time points (Fig 6) . There was no difference in hospital-based costs for the index admission or for subsequent limbrelated readmissions by stage when restricting the analysis to those surviving with functional limbs (P < .05; n ¼ 61; patients with missing functional status data, nonambulatory patients, and those who died were excluded). Age <80 years was independently associated with the highest quartile of in-hospital costs for the index admission (P < .05; Table V) . Baseline WIfI stage was significantly associated with cumulative in-hospital cost at 1 year and during the overall follow-up period (Table V) .
DISCUSSION
In line with several other recent reports, 5, [8] [9] [10] [11] our study demonstrates that the Society for Vascular Surgery WIfI classification system predicts midterm amputation risk and hospital costs in patients with chronic limb-threatening conditions. Patients admitted for treatment of foot wounds take >3.5 months to heal, and nearly half of the patients have recurrent symptoms downstream. These patients are frequently readmitted for limbrelated issues, and a quarter of them do not ambulate in the midterm despite maximal efforts and a multidisciplinary approach. A significant cost burden is associated with the care of patients with limb-threatening conditions. Mean direct cost for index hospitalization per intact limb for a WIfI stage 4 patient is more than U.S. $34,000 and increases to more than U.S. $52,000 by 1 year. This does not take into account the outpatient and indirect costs. Unlike a previously published study, 4 we did not find a significant difference in the inpatient costs between endovascular and open revascularization for patients in our study, which may reflect differences in practice patterns, use of adjunctive measures, and institutional cost structure. Our data suggest that early detection of wounds and prevention of progression to WIfI stage 4 should be a major focus of care of at-risk patients as it would both reduce major amputations and have a significant economic impact. In contrast to other reports, our study did not demonstrate a direct correlation between the WIfI stage and time to wound healing 6, 11 or ultimate functional status.
Similar to our findings, prior studies have shown poorer wound healing outcomes in patients with more severe degrees of ischemia. 10, 12 In our series, we did not separately analyze primary healing after surgical resection (eg, minor amputation) vs secondary healing of ulcers, likely a key confounder in this analysis. Preoperative functional status was a predictor of ambulatory status in the midterm in our cohort of patients, which has similarly been reported by others. [13] [14] [15] End-stage renal disease was a negative predictor of functional outcome. This information is important for selection of patients, shared decision-making, and setting of meaningful goals and expectations with patients and their families. Our second model was created to look at factors that could be potentially improved in relation to subsequent treatment choices and complications; however, we did not identify any unique factors predictive of functional status in this model. This likely reflects the modest cohort size and the inherent complexity of the functional status end point integrating comorbidities, frailty, unresolved limb symptoms, rehabilitation, and other factors.
Despite an aggressive multidisciplinary approach to management of these patients, 50% required readmission for limb care at some point in time during follow-up. This reflects a high incidence of recrudescent limb problems. In a retrospective review of endovascular interventions for critical limb ischemia, readmission rate was 54%, and wound healing was an important factor that affected readmissions. 16 Further efforts should focus on improving education of the patient and family, compliance with medical and podiatric care, rehabilitation and subacute wound care, and tools for home-based monitoring. WIfI stage at presentation. Limbs were not systematically restaged after procedures or at the time of every readmission. Wound healing and functional status data were collected on the basis of chart review or phone interview but not always by direct observation by a physician. Cost data were not available for the outpatient setting. Comparison of outcomes between groups is limited by selection bias of treatments applied. This is a single-center study with a small number of patients that may limit its general applicability.
CONCLUSIONS
We found that among patients hospitalized for limbthreatening conditions, initial WIfI stage was significantly associated with inpatient costs, cLOS, and midterm major amputation but not with ambulatory functional status, time to wound healing, or wound recurrence. Patients presenting with limb-threatening conditions require significant inpatient resources, have a high frequency of repeated hospitalizations, and are at increased risk for recurrent wounds and symptoms over time. WIfI stage 4 limbs require aggressive care, corresponding to the highest initial and aggregate hospital costs per limb saved. However, limb salvage can be achieved in these patients with a multidisciplinary team approach including podiatric and wound care, control of infection, optimal revascularization, and coordinated longitudinal care. 
